ReviewJournal of translational medicine2025
The differences in intestinal flora and metabolites between H-type hypertension and non-H-type hypertension.
Review in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveIn order to explore the differences in gut microbiota and their metabolites between patients with H-type hypertension and non-H-type hypertension.
methodOur study included 100 hypertensive patients from the Department of Cardiology at Shaoxing Second Hospital, with 51 patients having H-type hypertension (H group) and 49 having non-H-type hypertension (non-H group). Blood samples were collected for clinical and metabolite testing, and fecal samples were collected for 16 S rRNA sequencing and metabolite testing.
resultsNo significant difference in the α and β diversity of the gut microbiota between the two groups of patients were observed. However, at the phylum level, patients in the non-H group have a higher abundance of Firmicutes and a lower abundance of Actinobacteriota. At the genus level, compared to the non-H group, the H-type group has a higher abundance of Bifidobacterium; at the species level, the Non-H group has a higher abundance of Bacteroides vulgatus and lower abundances of Bacteroides stercoris and Bacteroides plebeius. In the serum of both groups, the concentrations of Acetate and Isobutyrate were significantly higher in the H group (P < 0.05), while in the feces of both groups of patients, the concentration of Malonate was significantly higher in the Non-H group.
conclusionThe microbial sequencing shows distinct differences between the H and non-H groups, with the latter having higher Firmicutes and Bacteroides vulgatus, while the H group has more Bifidobacterium and higher serum acetate levels. These variations suggest unique gut microbiota compositions and metabolite profiles for each group.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.